Correlation Between Defence Therapeutics and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Defence Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Defence Therapeutics and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Apellis Pharmaceuticals.
Diversification Opportunities for Defence Therapeutics and Apellis Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Defence and Apellis is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Defence Therapeutics and Apellis Pharmaceuticals
Assuming the 90 days horizon Defence Therapeutics is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Defence Therapeutics is 1.28 times more volatile than Apellis Pharmaceuticals. It trades about -0.1 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest 4,011 in Apellis Pharmaceuticals on September 1, 2024 and sell it today you would lose (618.00) from holding Apellis Pharmaceuticals or give up 15.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.44% |
| Values | Daily Returns |
Defence Therapeutics vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Defence Therapeutics |
| Apellis Pharmaceuticals |
Defence Therapeutics and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Defence Therapeutics and Apellis Pharmaceuticals
The main advantage of trading using opposite Defence Therapeutics and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Defence Therapeutics vs. Sino Biopharmaceutical Ltd | Defence Therapeutics vs. Institute of Biomedical | Defence Therapeutics vs. Aileron Therapeutics | Defence Therapeutics vs. Enlivex Therapeutics |
| Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |